Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:34 AM
Ignite Modification Date:
2025-12-25 @ 2:34 AM
NCT ID:
NCT07297134
Eligibility Criteria:
Inclusion Criteria:
Female individuals aged ≥18 years Ability to provide written informed consent Group I (Metastatic BC): Histopathologically confirmed breast cancer and radiologically or clinically proven distant organ metastasis at the time of enrollment Group II (Non-Metastatic BC): Histopathologically confirmed breast cancer with no evidence of distant metastasis Group III (Healthy Controls): Women ≥18 years with no known breast disease and no personal history of malignancy
Exclusion Criteria:
History of any other primary malignancy Known breast disease or breast cancer diagnosis in Group III Immunosuppressive therapy that may alter immune or biomarker profiles Active infection or inflammatory condition that may alter biomarker levels Inability or unwillingness to provide informed consent Severe hepatic, renal, or hematologic dysfunction Current pregnancy or lactation
Healthy Volunteers:
True
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT07297134
Study Brief:
Protocol Section:
NCT07297134